Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Receives $19.33 Consensus Price Target from Analysts

Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) have been assigned an average rating of “Moderate Buy” from the seven ratings firms that are presently covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $19.33.

SBRA has been the subject of several analyst reports. Mizuho restated a “neutral” rating and set a $20.00 target price on shares of Sabra Health Care REIT in a research report on Thursday, December 5th. Truist Financial lifted their price objective on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “hold” rating in a report on Tuesday, March 18th. Citizens Jmp raised shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 7th. Finally, JMP Securities raised shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price target for the company in a report on Tuesday, January 7th.

Hedge Funds Weigh In On Sabra Health Care REIT

A number of large investors have recently modified their holdings of SBRA. VSM Wealth Advisory LLC bought a new stake in shares of Sabra Health Care REIT during the fourth quarter worth $26,000. Quarry LP acquired a new stake in Sabra Health Care REIT in the third quarter worth about $30,000. Assetmark Inc. raised its holdings in Sabra Health Care REIT by 33.4% during the 4th quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust’s stock worth $45,000 after purchasing an additional 656 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new position in Sabra Health Care REIT during the 3rd quarter valued at about $59,000. Finally, GF Fund Management CO. LTD. bought a new position in shares of Sabra Health Care REIT in the 4th quarter valued at about $74,000. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Sabra Health Care REIT Trading Up 0.9 %

Shares of Sabra Health Care REIT stock opened at $17.54 on Monday. Sabra Health Care REIT has a 52-week low of $13.31 and a 52-week high of $20.03. The firm has a market capitalization of $4.17 billion, a PE ratio of 33.09, a price-to-earnings-growth ratio of 1.97 and a beta of 1.27. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16. The company’s fifty day moving average price is $16.83 and its two-hundred day moving average price is $17.68.

Sabra Health Care REIT (NASDAQ:SBRA) last posted its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.36. The business had revenue of $182.35 million for the quarter, compared to analysts’ expectations of $178.01 million. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. On average, analysts expect that Sabra Health Care REIT will post 1.45 EPS for the current year.

Sabra Health Care REIT Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Friday, February 14th were issued a $0.30 dividend. The ex-dividend date was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.84%. Sabra Health Care REIT’s dividend payout ratio is 226.42%.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.